Randomized, placebo-controlled study of oregovamab for consolidation of clinical remission in patients with advanced ovarian cancer

Author: Tait David  

Publisher: Informa Healthcare

ISSN: 1473-3404

Source: The Women's Oncology Review, Vol.5, Iss.1, 2005-03, pp. : 27-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content